Compounds > 3,3',4'-trihydroxyflavone
Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and guanosine 5'-o-(3-thiotriphosphate)

3,3',4'-trihydroxyflavone has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies

Compound Research Comparison

Studies
(3,3',4'-trihydroxyflavone)		Trials
(3,3',4'-trihydroxyflavone)		Recent Studies (post-2010)
(3,3',4'-trihydroxyflavone)		Studies
(guanosine 5'-o-(3-thiotriphosphate))		Trials
(guanosine 5'-o-(3-thiotriphosphate))		Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate))
390225,5428368

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HY; Kim, IK; Seok, YM; Williams, SJ; Woodman, OL1

Other Studies

1 other study(ies) available for 3,3',4'-trihydroxyflavone and guanosine 5'-o-(3-thiotriphosphate)

ArticleYear
3',4'-Dihydroxyflavonol reduces vascular contraction through Ca²⁺ desensitization in permeabilized rat mesenteric artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:2

    Topics: Animals; Calcium; Cardiovascular Agents; Escin; Flavonols; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Mesenteric Arteries; Permeability; Phenylephrine; Rats; Rats, Sprague-Dawley; Sodium Fluoride; Vasoconstriction

2012